Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    Blood pressure management: individualized treatment based on absolute risk and the potential for benefit.

    Alderman MH.

    Ann Intern Med. 1993 Aug 15;119(4):329-35. Review.PMID: 8328743 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

    Law M, Wald N, Morris J.

    Health Technol Assess. 2003;7(31):1-94. Review.PMID: 14604498 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    JNC V revisited: standard of care or individualized treatment for hypertension?

    Alderman MH.

    Am Heart J. 1998 Feb;135(2 Pt 2):S8-15.PMID: 9488607 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Hypertension as a function of age]

    Gensini GF, Corradi F.

    Ital Heart J. 2000 Jun;1 Suppl 2:23-31. Review. Italian. PMID: 10905125 [PubMed - indexed for MEDLINE]Related articles

    5.

    Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.

    Jackson R.

    J Hum Hypertens. 1998 Sep;12(9):607-13. Review.PMID: 9783489 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lack of control of high blood pressure and treatment recommendations in Canada.

    Khan N, Chockalingam A, Campbell NR.

    Can J Cardiol. 2002 Jun;18(6):657-61.PMID: 12107423 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Metabolic and cardiovascular characteristics of hypertension. Familial aspects.

    Neutel JM, Smith DH.

    Cardiol Clin. 1995 Nov;13(4):539-47. Review.PMID: 8565017 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk predictors, risk indicators, and benefit factors in hypertension.

    Dollery CT.

    Am J Med. 1987 Jan 5;82(1A):2-8.PMID: 3799698 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiovascular risks of hypertension: lessons from observational studies.

    O'Donnell CJ, Kannel WB.

    J Hypertens Suppl. 1998 Oct;16(6):S3-7. Review.PMID: 9856377 [PubMed - indexed for MEDLINE]Related articles

    10.

    Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment.

    Alderman MH, Cohen H, Madhavan S.

    J Hypertens. 1998 Jun;16(6):761-9.PMID: 9663916 [PubMed - indexed for MEDLINE]Related articles

    11.

    Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.

    Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK.

    J Intern Med. 2005 Jun;257(6):496-502.PMID: 15910553 [PubMed - indexed for MEDLINE]Related articles

    12.

    Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.

    Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta T; CASE-J Study Group.

    Hypertens Res. 2003 Dec;26(12):979-90. Review.PMID: 14717341 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.

    Gueyffier F, Boissel JP, Boutitie F, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Kerlikowske K, Perry M, Prineas R, Schron E.

    Stroke. 1997 Dec;28(12):2557-62.PMID: 9412649 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The Hypertension Optimal Treatment study and the importance of lowering blood pressure.

    Hansson L.

    J Hypertens Suppl. 1999 Feb;17(1):S9-13.PMID: 10340838 [PubMed - indexed for MEDLINE]Related articles

    15.

    The role of systolic blood pressure in determining risk for cardiovascular disease.

    Levy D.

    J Hypertens Suppl. 1999 Feb;17(1):S15-8. Review.PMID: 10340839 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]

    Oparil S, Bakir SE.

    Drugs. 2000;59 Spec No 2:25-37. Review. French. PMID: 11002856 [PubMed - indexed for MEDLINE]Related articles

    17.

    Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.

    Green R, Kwok S, Durrington PN.

    QJM. 2002 Dec;95(12):821-6.PMID: 12454325 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Management of hypertension and cerebrovascular disease in the elderly.

    Pedelty L, Gorelick PB.

    Am J Med. 2008 Aug;121(8 Suppl):S23-31. Review.PMID: 18638616 [PubMed - indexed for MEDLINE]Related articles

    19.

    Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.

    He J, Whelton PK.

    J Hypertens Suppl. 1999 Jun;17(2):S7-13.PMID: 10465061 [PubMed - indexed for MEDLINE]Related articles

    20.

    Implications of the links between hypertension and myocardial infarction for choice of drug therapy in patients with hypertension.

    Meredith PA.

    Am Heart J. 1996 Jul;132(1 Pt 2 Su):222-8. Review.PMID: 8677860 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data